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functional sperm parameters). Stepwise multiple regression 
analysis on all of the parameters (male and female) yielded two 
estimation curves only related to non sperm parameters:
PRICSI=1.608412-0.03 6848* AGE-0.046633*DURA (AGE=years
of age of the female; DURA=duration of infertility in years) 
JRICSI=0.609082-0.017673 *AGE
Conclusion: individualization of expected pregnancy rates and 
implantation rates for I VF and ICSI is possible; the estimation 
curves should be made for each centre; ICSI curves are not 
related to any sperm parameter,
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The introduction of ICSI offered a successful treatment option 
for severe male subfertility, although the etiology of the 
disorder remains unclear in most cases. Recently, microdeletions 
in the AZF-region of the Y chromosome have been detected in 
men with azoospermia or severe oligospermia.
In tin is study we investigated the prevalence of microdeletions 
in the AZFc-region of the Y chromosome in our ICSI-popuIation 
(by PCR analysis) and looked for clinical differences between 
the men with and without the deletion,
Blood was drawn from 154 men, who were waiting for ICSI 
treatment: 24 azoospermie men, 98 oligospermie and 32 
normospermie men (after previous fertilization failure). 
Chromosome analysis showed 4 Klinefelters in the azoospermie 
group and 2 Klinefelters in the oligospermie group. One 
translocation was observed in the oligospermie group.
Microdeletions in the AZFc region were present in 7 of the 98 
oligospermie men (7%). None of these 7 men had abnormal 
findings on andrologic history and examination, No 
microdeletions were found in the azoospermie and normospermie 
group.
We conclude that microdeletions in the AZFc-region of the 
Y-chromosome are frequently found in men with severe 
oligospermia. Therefore, we recommend DNA-screening (and 
genetic counseling) to all ICSI-men.
46. Vasectomy, vasovasostomy and MESA/ICSI: is it the future 
triad of vasectomised man who regrets vasectomy?
M.T. W.T. Lock, H. Roshani, Dept, Urology and P. Kastrop, Dept. 
OBGYN, Univ. Hosp. Utrecht, Utrecht, The Netherlands.
Introduction: We studied the pregnancy and patency rate of 
our micro-surgical and our MESA/ICSI treatments to evaluate 
the future roll of the micro-manipulation and vasovasostomy in 
the case of vasectomized man.
Patients and methods: A number of 84 men underwent 
vasovasostomy. The hormonal state of FSH, LH and 
testosterone were studied. Two layer technique as described 
by Silber was used. Testis biopsies were taken peroperatively. 
Semen analysis occurred per 3 months post-operativcly during 
one year. Six months after the operation the data were refreshed.
Results: Nine men didn’t cooperate to examine the semen. The 
patency of the vas was reversed at 75% (56/75) of the cases. Six 
patients lost their child wish. The number of 69 patients were 
divided in three groups: group A; (fertile group) n=21 (30%) 
with average spermatozoa counts (ASC) of 37dbl9 (12-82) X106/ 
ml, group B; (subfertile group) n=29 (42%) with ASC of 20±21 
(1-79) XIOVml and an azoospermic group C, n= 19 (28%). Ten 
couples from group C were treated by MESA/ICSI. Seven 
healthy children have been already bom. Since 1-4-1996 MESA- 
treatments were stopped in the Netherlands, There was a 
significant difference between group A and B (only) in the sperm 
counts (P<0.05). A, B and C were not statistically significant 
different concerning the hormonal state and the testis biopsies 
score. The interval between the vasectomy and the 
vasovasostomy was 10.8±4.1 and 6.7±2.5 years in azoospermic 
respectively fertile group (p=0.001).
Conclusions: MESA/ ICSI (efficacy 70%) is a powerful tool in 
case of vasectomised and then vasovasostomized men when 
azoospermia persists.
47, Testis-specific histone 2B in human spermatozoa
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During the first part of mammalian spermatogenesis, somatic 
type histones are partly replaced by testis-specific histone 
variants. In spermatids, the histones are replaced by transition 
proteins and subsequently by protamines, which allow sperm 
nuclear condensation. In contrast to other species, in mature 
sperm of the human about 10% of the histones are still present. 
The aim of the present study was to determine the expression of 
testis-specific histone 2B (TH2B) in human testis tissue, and to 
establish the concentration of TH2B in ejaculated spermatozoa 
of patients visiting our andrology clinic. In histological sections 
of testicular biopsies, spermatocytes, and round and elongating 
spermatids immunoreacted strongly with an antibody targeting 
TH2B, Also, spermatozoa obtained from semen immunostained, 
when decondensed to make the nuclear proteins accessible to 
the antibody. There was, however, a remarkable intercellular 
variability in the intensity of staining of spermatozoa within one 
ejaculate. Immunoblotting of sperm proteins confirmed the 
presence of TIT2B, and indicated that also the mean 
concentration of TH2B in spermatozoa varies among patients. 
The biological and clinical significance of the TH2B level in 
human spermatozoa is currently being investigated,
48. Identification of pro-ncrve growth factor in rat round 
spermatids: potential role as a trophic factor in the maintenance 
of Sertoli cell viability.
D. Djakiew & Y. Chen, The Department of Cell Biology, 
Georgetown University Medical Center, 3900 Reservoir Rd, N. W., 
Washington, D.C., U.S.A.
*
A nerve growth factor (NGF) immunoreactive protein expressed 
by round spermatids (RS) is thought to interact with NGF
